Gedeon Richter releases updated prescribing information for Laktinet-Rihter

Gedeon Richter has issued updated clinical guidance for its contraceptive product Laktinet-Rihter. The medication, categorized as a progestogen-only pill, utilizes desogestrel to prevent pregnancy by inhibiting ovulation.

Designed for women who cannot use estrogen-based contraceptives, the product is indicated for adults aged 18 and older. Gedeon Richter notes that because the formulation lacks estrogen, it remains an option for breastfeeding mothers. However, the company warns that irregular vaginal bleeding is a potential side effect for users.

The updated documentation highlights significant contraindications, including current or past venous thrombosis, liver disease, and hormone-sensitive malignancies. Patients with pre-existing conditions such as diabetes, epilepsy, or hypertension are advised to consult a healthcare provider, as the drug requires careful monitoring to mitigate risks.